233 related articles for article (PubMed ID: 25331796)
1. Modulation of liver-intestine cadherin (Cadherin 17) expression, ERK phosphorylation and WNT signaling in EPHB6 receptor-expressing MDA-MB-231 cells.
Bhushan L; Tavitian N; Dey D; Tumur Z; Parsa C; Kandpal RP
Cancer Genomics Proteomics; 2014; 11(5):239-49. PubMed ID: 25331796
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinase-deficient EphB6 receptor-dependent alterations in proteomic profiles of invasive breast carcinoma cells as determined by difference gel electrophoresis.
Kandpal RP
Cancer Genomics Proteomics; 2010; 7(5):253-60. PubMed ID: 20952760
[TBL] [Abstract][Full Text] [Related]
3. EPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells.
Johnson C; Segovia B; Kandpal RP
Cancer Genomics Proteomics; 2016 09-10; 13(5):359-68. PubMed ID: 27566654
[TBL] [Abstract][Full Text] [Related]
4. The kinase defective EPHB6 receptor tyrosine kinase activates MAP kinase signaling in lung adenocarcinoma.
Yu J; Bulk E; Ji P; Hascher A; Koschmieder S; Berdel WE; Müller-Tidow C
Int J Oncol; 2009 Jul; 35(1):175-9. PubMed ID: 19513565
[TBL] [Abstract][Full Text] [Related]
5. Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration.
Ryu YK; Lee YS; Lee GH; Song KS; Kim YS; Moon EY
Int J Cancer; 2012 Nov; 131(9):2067-77. PubMed ID: 22328534
[TBL] [Abstract][Full Text] [Related]
6. The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells.
Truitt L; Freywald T; DeCoteau J; Sharfe N; Freywald A
Cancer Res; 2010 Feb; 70(3):1141-53. PubMed ID: 20086179
[TBL] [Abstract][Full Text] [Related]
7. A paradigm shift in EPH receptor interaction: biological relevance of EPHB6 interaction with EPHA2 and EPHB2 in breast carcinoma cell lines.
Fox BP; Kandpal RP
Cancer Genomics Proteomics; 2011; 8(4):185-93. PubMed ID: 21737611
[TBL] [Abstract][Full Text] [Related]
8. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β.
Choi CH; Lee BH; Ahn SG; Oh SH
Biochem Biophys Res Commun; 2012 Feb; 418(4):759-64. PubMed ID: 22310719
[TBL] [Abstract][Full Text] [Related]
10. Wnt/β-catenin signaling pathway and thioredoxin-interacting protein (TXNIP) mediate the "glucose sensor" mechanism in metastatic breast cancer-derived cells MDA-MB-231.
Vaira S; Friday E; Scott K; Conrad S; Turturro F
J Cell Physiol; 2012 Feb; 227(2):578-86. PubMed ID: 21448924
[TBL] [Abstract][Full Text] [Related]
11. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
12. ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
[TBL] [Abstract][Full Text] [Related]
13. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast.
Prasad CP; Rath G; Mathur S; Bhatnagar D; Parshad R; Ralhan R
BMC Cancer; 2009 Sep; 9():325. PubMed ID: 19751508
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of tetrahydropyridinol derivatives on β-catenin signaling and invasion in human hepatocellular and breast carcinoma cells.
Yadunandam AK; Yoon JS; Jeong YT; Kim WY; Lee SY; Kim GD
Int J Mol Med; 2015 Aug; 36(2):577-87. PubMed ID: 26059838
[TBL] [Abstract][Full Text] [Related]
16. High glucose and insulin differentially modulates proliferation in MCF-7 and MDA-MB-231 cells.
Gupta C; Tikoo K
J Mol Endocrinol; 2013; 51(1):119-29. PubMed ID: 23690508
[TBL] [Abstract][Full Text] [Related]
17. EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells.
Fox BP; Kandpal RP
Oncogene; 2009 Apr; 28(14):1706-13. PubMed ID: 19234485
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.
Wang Y; Lam JB; Lam KS; Liu J; Lam MC; Hoo RL; Wu D; Cooper GJ; Xu A
Cancer Res; 2006 Dec; 66(23):11462-70. PubMed ID: 17145894
[TBL] [Abstract][Full Text] [Related]
19. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
20. EphB6 receptor modulates micro RNA profile of breast carcinoma cells.
Bhushan L; Kandpal RP
PLoS One; 2011; 6(7):e22484. PubMed ID: 21811619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]